- Home
- ARWR vs LEVI Comparison
ARWR vs LEVI Comparison
Compare ARWR & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | LEVI |
|---|---|---|
| Founded | 2003 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.0B |
| IPO Year | 2009 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARWR | LEVI |
|---|---|---|
| Price | $73.24 | $22.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $83.40 | $26.92 |
| AVG Volume (30 Days) | 1.6M | ★ 2.6M |
| Earning Date | 05-07-2026 | 04-07-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | 99.80 | ★ 178.85 |
| EPS | N/A | ★ 0.45 |
| Revenue | $16,142,321.00 | ★ $6,282,000,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $4.82 |
| P/E Ratio | $353.91 | ★ $50.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.30 | $16.50 |
| 52 Week High | $79.48 | $24.82 |
Technical Indicators
Market Signals| Indicator | ARWR | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 58.65 |
| Support Level | $60.60 | $21.59 |
| Resistance Level | $76.45 | $23.40 |
| Average True Range (ATR) | 3.58 | 0.66 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 40.58 | 50.90 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.